ASTA MEDICA AKTIENGESELLSCHAFT

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 268
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C01B NON-METALLIC ELEMENTS; COMPOUNDS THEREOF178
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
  
 
C08K USE OF INORGANIC OR NON-MACROMOLECULAR ORGANIC SUBSTANCES AS COMPOUNDING INGREDIENTS 1101

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8173592 Method for a programmed controlled ovarian stimulation protocolMar 10, 00May 08, 12[A61K, A61P, C07K]
6627609 LHRH antagonists having improved solubility propertiesMar 14, 00Sep 30, 03[A61K]
6180076 Readily dispersible precipitated silicaSep 15, 98Jan 30, 01[C01B, C08K]
5723463 Pyrido ?3,2-E!pyrazinones with anti-asthmatic action and processes for their manufactureMar 25, 96Mar 03, 98[A61K, C07D]
5449798 Phospholipid derivatives containing higher elements of the fifth groupSep 22, 93Sep 12, 95[C07F]
5262169 Tablets and granulates containing mesna as active substanceJul 16, 91Nov 16, 93[A61K]
5219866 Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparationJul 01, 92Jun 15, 93[A61K, C07F]
5158776 Solid oral dosage forms of ifosfamideJul 24, 91Oct 27, 92[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
6727252 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compoundsExpiredOct 16, 00Apr 27, 04[A61K]
2003/0119,906 Pharmaceutical forms for the oral administration of mesnaAbandonedJan 03, 03Jun 26, 03[A61K]
6576624 Use of dopamine receptor antagonists in palliative tumor therapyExpiredJun 23, 00Jun 10, 03[A61K]
2002/0119,194 Pharmaceutical forms for the oral administration of mesnaAbandonedOct 19, 01Aug 29, 02[A61K]
6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor actionExpiredDec 15, 00Aug 13, 02[A01N]
6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferationExpiredMay 04, 99Jun 18, 02[A61K, C07D]
2001/0046,504 CYCLOPHOSPHAMIDE FILM-COATED TABLETSAbandonedJun 15, 99Nov 29, 01[A61K]
2001/0047,103 Process for the preparation of oxazaphosphorine-2-aminesAbandonedDec 07, 00Nov 29, 01[C07F]
6258815 Specific immunophilin ligands as antiasthmatics and immunosuppressantsExpiredApr 25, 97Jul 10, 01[A01N, C07D]
6251932 Immunophilin ligandsExpiredSep 25, 98Jun 26, 01[A61K, C07D]
6093728 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compoundsExpiredSep 23, 98Jul 25, 00[A61K, C07D]
5985834 Nova- and decapeptides in the preparation of a drug for the treatment of aidsExpiredDec 18, 95Nov 16, 99[A61K]
5965582 N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunemodulating effectExpiredMay 12, 97Oct 12, 99[A61K, C07D]
5958906 Phospholipid derivatives containing higher elements of the fifth main groupExpiredMay 07, 97Sep 28, 99[A61K]
5942493 LH-RH antagonists having improved actionExpiredMay 28, 98Aug 24, 99[A61K, C07K]
5916998 Copolymers with polyester polycarbonate blocks containing poly(caprolactone) segments, and use thereof for the preparation of biodegradable matricesExpiredFeb 07, 97Jun 29, 99[C08G]
5837462 Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugsExpiredNov 08, 96Nov 17, 98[C12Q]
5770574 Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory propertiesExpiredJun 19, 97Jun 23, 98[A61K, C07K]
5691379 Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissueExpiredMar 15, 96Nov 25, 97[A61K]
5637577 Phospholipid derivatives containing higher elements of the fifth groupExpiredApr 14, 95Jun 10, 97[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.